Handel międzynarodowy · 6.02.1995

Certain Salinomycin Biomass and Preparations Containing Same; Notice of Investigation

Notice is hereby given that a complaint and a motion for temporary relief were filed with the U.S. International Trade Commission on December 23, 1994, under section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on behalf of Kaken Pharmaceutical Company, Ltd., 2-28-8 Honkomagome, Bunkyo-ku, Tokyo 113, Japan. A revised complaint and revised memorandum of points and authorities [[Page 7070]] in support of the motion for temporary relief were filed on January 18, 1995. The complaint, as revised, alleges violations of section 337 in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain salinomycin biomass and preparations containing same alleged to be manufactured abroad by a method covered by claim 2 of U.S. Letters Patent Re. 34,698 and alleged to incorporate ``know-how'' and improvements in breach of contract. The complaint further alleges that there exists an industry in the United States and that the domestic industry is being injured or threatened with injury by the imported accused products. The complainant requests that the Commission institute an investigation and, after a full investig